{"database": "openregs", "table": "documents", "rows": [["FDA-2023-N-0795-0004", "FDA", "FDA-2023-N-0795", "Reference 7 - Shengchao-s12874-017-0353-1 RE Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising", "Supporting & Related Material", "Background Material", "2023-04-26T04:00:00Z", 2023, 4, null, null, "2023-04-26T19:38:32Z", null, 0, 0, "090000648598ca75"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2023-N-0795-0004"], "units": {}, "query_ms": 0.48380903899669647, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}